Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Allergan Company Profile (NYSE:AGN)

Consensus Ratings for Allergan (NYSE:AGN) (?)
Ratings Breakdown: 12 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: $212.73 (11.44% downside)

Current Analysts' Coverage Summary for Allergan (NYSE:AGN)
Show:
DateFirmActionRatingPrice TargetActions
2/10/2015SusquehannaDowngradePositive -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2015Leerink SwannDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015BTIG ResearchDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014Goldman SachsDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014Stifel NicolausDowngradeBuy -> Hold$200.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014Citigroup Inc.Reiterated RatingBuy$210.00 -> $245.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2014BarclaysInitiated CoverageEqual Weight$208.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2014Jefferies GroupReiterated RatingHold$184.00 -> $219.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2014Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2014GuggenheimDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2014SunTrustDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2014William BlairDowngradeOutperform -> Market Perform$219.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2014Deutsche BankReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014Evercore ISIInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2014JPMorgan Chase & Co.Reiterated RatingOverweight$190.00 -> $200.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2014BMO Capital MarketsBoost Price TargetOutperform$202.00 -> $230.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2014Credit SuisseDowngradeOutperform -> Neutral$190.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2014Buckingham ResearchUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2014Piper JaffrayReiterated RatingNeutral -> Neutral$164.00 -> $170.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2014Sterne Agee CRTBoost Price Target$185.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2014Edward JonesDowngradeHold -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2014ArgusDowngradeBuy -> Hold$130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2014Morgan StanleyReiterated RatingEqual Weight$94.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2014RBC CapitalInitiated CoverageOutperform$131.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/20/2013Sanford C. BernsteinBoost Price Target$105.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/17/2013JMP SecuritiesReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/11/2013Lazard Capital MarketsLower Price TargetBuy$115.00 -> $100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2013Canaccord GenuitySet Price TargetHold$111.00 -> $98.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2013 forward)